Value-based pricing of drugs with multiple indications or in combinations — lessons from Europe

Overview of attention for article published in Nature Reviews Clinical Oncology, September 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 5 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 7 Mendeley

Summary Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 1 blog post.

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health, 20 Oct 2021

By Ameet Sarpatwari, Alexander Egilman, Aviva Wang, and Aaron S.